Cargando…
SV-BR-1-GM, a Clinically Effective GM-CSF-Secreting Breast Cancer Cell Line, Expresses an Immune Signature and Directly Activates CD4(+) T Lymphocytes
Targeted cancer immunotherapy with irradiated, granulocyte–macrophage colony-stimulating factor (GM-CSF)-secreting, allogeneic cancer cell lines has been an effective approach to reduce tumor burden in several patients. It is generally assumed that to be effective, these cell lines need to express i...
Autores principales: | Lacher, Markus D., Bauer, Gerhard, Fury, Brian, Graeve, Sanne, Fledderman, Emily L., Petrie, Tye D., Coleal-Bergum, Dane P., Hackett, Tia, Perotti, Nicholas H., Kong, Ying Y., Kwok, William W., Wagner, Joseph P., Wiseman, Charles L., Williams, William V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5962696/ https://www.ncbi.nlm.nih.gov/pubmed/29867922 http://dx.doi.org/10.3389/fimmu.2018.00776 |
Ejemplares similares
-
GM-CSF in inflammation
por: Hamilton, John A.
Publicado: (2019) -
Recombinant GM-CSF for diseases of GM-CSF insufficiency: Correcting dysfunctional mononuclear phagocyte disorders
por: Lazarus, Hillard M., et al.
Publicado: (2023) -
G-CSF and GM-CSF in clinical trials.
por: Antman, K. H.
Publicado: (1990) -
The efficacy and safety of targeting GM-CSF in arthritis
por: Bykerk, Vivian P
Publicado: (2020) -
GM-CSF-Dependent Inflammatory Pathways
por: Hamilton, John A.
Publicado: (2019)